News | Antiplatelet and Anticoagulation Therapies

A new study shows the use of novel anticoagulants to treat atrial fibrillation (AF) on an “as needed basis” guided by diligent pulse monitoring can be an effective and safe way to lower overall risk of stroke.

Home May 09, 2016
Home
News | Pacemakers

May 9, 2016 — New data presented at the Heart Rhythm Society's (HRS) annual meeting highlighted the long-term safety of ...

Home May 09, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

A new study has found an increased risk of dementia in patients with atrial fibrillation (AF) that receive long-term blood thinner warfarin (Coumadin) compared to patients that use warfarin for conditions other than AF.

Home May 09, 2016
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

May 9, 2016 —St. Jude Medical announced presentation of the MultiPoint Pacing (MPP) Investigational device exemption ...

Home May 09, 2016
Home
News | Atrial Fibrillation

May 9, 2016 — A new study presented at the Heart Rhythm Society’s 37th Annual Scientific Sessions, found that among ...

Home May 09, 2016
Home
News | Implantable Cardioverter Defibrillator (ICD)

May 9, 2016 — Medtronic announced the results of several studies evaluating a novel approach to implantable cardioverter ...

Home May 09, 2016
Home
S-ICD, Effortless
Feature | Implantable Cardioverter Defibrillator (ICD)

May 9, 2016 — The mid to long-term results from the EFFORTLESS study, the largest subcutaneous implantable cardioverter ...

Home May 09, 2016
Home
Feature | EP Lab

May 9, 2016 – A new, large study shows that 95.7 percent of individual leads were successfully removed using a procedure ...

Home May 09, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

Atrial fibrillation patients taking warfarin are at higher risk of developing kidney failure if anticoagulation levels are not properly managed, according to a new study from researchers at the Intermountain Medical Center Heart Institute.

Home May 06, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

The largest risk-directed study by a national hospital system demonstrates a 40 percent decline in bleeding events for percutaneous coronary intervention (PCI) patients and a significant reduction in pharmacy costs.

Home May 06, 2016
Home
News | Cardio-oncology

The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus statement providing cardiologists, oncologists and internal medicine physicians guidance for treating patients facing concomitant cardiovascular disease and cancer.

Home May 06, 2016
Home
News | Atherectomy Devices

May 6, 2016 — Cardiovascular Systems Inc. shared three-year results from its pivotal ORBIT II study in a featured ...

Home May 06, 2016
Home
News | Peripheral Artery Disease (PAD)

Intact Vascular Inc. announced that positive twelve-month results from its Tack Optimized Balloon Angioplasty – Below-the-Knee (TOBA-BTK) clinical study were presented at the SCAI 2016 conference.

Home May 05, 2016
Home
News | Cath Lab

May 5, 2016 — The Society for Cardiovascular Angiography and Interventions (SCAI) published an update to its 2012 paper ...

Home May 05, 2016
Home
News | SPECT-CT

Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose and monitor diseases at a functional level with GE Healthcare’s next-generation SPECT/CT system, Discovery NM/CT 670 CZT.

Home May 05, 2016
Home
Subscribe Now